Founded in 1963, bioMérieux S.A. provides diagnostic solutions that determine the source of disease and contamination to guide medical decisions and monitor industrial production quality. The company's business is divided into clinical applications—which account for the vast majority of revenue and include molecular biology, microbiology, and immunoassays—and industrial applications for microbiological quality testing. Key product platforms include the BIOFIRE and SPOTFIRE syndromic testing systems, as well as the VITEK automated microbiology systems. Headquartered in Marcy-l'Étoile, France, bioMérieux generates over 90% of its sales outside of its home country, with significant market presence in the Americas, EMEA, and Asia-Pacific regions. The company operates a "razor-and-blades" business model, selling diagnostic instruments followed by recurring sales of proprietary disposable reagents and service contracts.
